Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Lucibello

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cellular & Molecular Biology Letters|July 7, 2025
AKT and DUBs: a bidirectional relationshipValentina Serratore, Maria Lucibello, Donatella Malanga, et al.
Antioxidants & Redox Signaling|May 3, 2011
The cystine/cysteine cycle and GSH are independent and crucial antioxidant systems in malignant melanoma cells and represent druggable targetsRoberta Venè, Patrizia Castellani, Laura Delfino, et al.
Cancer Drug Resistance (Alhambra, Calif.)|October 16, 2023
Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapyGianluca Santamaria, Mario Cioce, Antonia Rizzuto, et al.
Experimental Cell Research|August 2, 2011
TCTP is a critical survival factor that protects cancer cells from oxidative stress-induced cell-deathMaria Lucibello, Alessandra Gambacurta, Manuela Zonfrillo, et al.
Frontiers in Pharmacology|April 28, 2025
Bioinformatic challenges for pharmacogenomic study: tools for genomic data analysisMariamena Arbitrio, Marianna Milano, Maria Lucibello, et al.
The Journal of Biological Chemistry|January 16, 2004
Nerve growth factor-dependent survival of CESS B cell line is mediated by increased expression and decreased degradation of MAPK phosphatase 1Paolo Rosini, Giovanna De Chiara, Paolo Bonini, et al.
Cancer Drug Resistance (Alhambra, Calif.)|December 3, 2024
Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunityMario Cioce, Mariamena Arbitrio, Nicoletta Polerà, et al.
Cells|November 23, 2019
A Novel 3D Scaffold for Cell Growth to Asses Electroporation EfficacyMonica Dettin, Elisabetta Sieni, Annj Zamuner, et al.
Oncotarget|March 18, 2015
Phospho-TCTP as a therapeutic target of Dihydroartemisinin for aggressive breast cancer cellsMaria Lucibello, Sara Adanti, Ester Antelmi, et al.
Chemico-Biological Interactions|January 11, 2026
Upregulation of ACHE and BACE2 genes by Oleacein in Alzheimer's Disease and NeuroblastomaNicoletta Polerà, Giada Juli, Giuseppe Agapito, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cellular & Molecular Biology Letters|July 7, 2025
AKT and DUBs: a bidirectional relationshipValentina Serratore, Maria Lucibello, Donatella Malanga, et al.
Antioxidants & Redox Signaling|May 3, 2011
The cystine/cysteine cycle and GSH are independent and crucial antioxidant systems in malignant melanoma cells and represent druggable targetsRoberta Venè, Patrizia Castellani, Laura Delfino, et al.
Cancer Drug Resistance (Alhambra, Calif.)|October 16, 2023
Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapyGianluca Santamaria, Mario Cioce, Antonia Rizzuto, et al.
Experimental Cell Research|August 2, 2011
TCTP is a critical survival factor that protects cancer cells from oxidative stress-induced cell-deathMaria Lucibello, Alessandra Gambacurta, Manuela Zonfrillo, et al.
Frontiers in Pharmacology|April 28, 2025
Bioinformatic challenges for pharmacogenomic study: tools for genomic data analysisMariamena Arbitrio, Marianna Milano, Maria Lucibello, et al.
The Journal of Biological Chemistry|January 16, 2004
Nerve growth factor-dependent survival of CESS B cell line is mediated by increased expression and decreased degradation of MAPK phosphatase 1Paolo Rosini, Giovanna De Chiara, Paolo Bonini, et al.
Cancer Drug Resistance (Alhambra, Calif.)|December 3, 2024
Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunityMario Cioce, Mariamena Arbitrio, Nicoletta Polerà, et al.
Cells|November 23, 2019
A Novel 3D Scaffold for Cell Growth to Asses Electroporation EfficacyMonica Dettin, Elisabetta Sieni, Annj Zamuner, et al.
Oncotarget|March 18, 2015
Phospho-TCTP as a therapeutic target of Dihydroartemisinin for aggressive breast cancer cellsMaria Lucibello, Sara Adanti, Ester Antelmi, et al.
Chemico-Biological Interactions|January 11, 2026
Upregulation of ACHE and BACE2 genes by Oleacein in Alzheimer's Disease and NeuroblastomaNicoletta Polerà, Giada Juli, Giuseppe Agapito, et al.
Pageof 2